Medical Malpractice Insurance for California Functional and Integrative Medicine

Functional and integrative medicine describe an approach, not a clinical permission slip. A patient with fatigue, sleep disruption, weight change, and a stack of online results still needs an assessment that distinguishes routine care, urgent workup, referral, watchful follow-up, and uncertainty. The physician's first task is not to sell a package. It is to make the clinical reasoning visible.

Turn the philosophy into a care pathway

For each program, name the population or problem, clinical rationale, tests, what a result can and cannot establish, decision thresholds, alternatives including no treatment, contraindications or interactions, and the clinician who owns the response. A phrase such as "root cause" or "optimization" does not identify a diagnosis, test indication, or treatment decision.

Use the focused guides for infusions, injections, weight loss, hormones, procedures, and telehealth when those services become part of the practice. They are not interchangeable add-ons.

The test is not the clinical decision

Separate an outside laboratory order, onsite testing, home kit, wearable, and patient-uploaded data. For each, identify the origin, reviewer, uncertainty or limitation, escalation, documentation, and closure. Consumer data can become clinical information when a clinician relies on it to make a recommendation.

CLIA's research exception applies only when a laboratory does not report patient-specific results for diagnosis, prevention, treatment, or individual health assessment. A California testing site generally needs both a California clinical-laboratory license and the relevant federal CLIA certificate. Do not use a research label to obscure a result that enters patient care. If the practice performs waived testing, identify the authorized performers and laboratory director; delegation does not remove the director's responsibility for the laboratory system.

The practice should define who reviews a result, documents the clinical assessment, contacts the patient when needed, and closes or escalates the task. A portal PDF is not a clinical decision.

Products are not one category

Supplements, commercial drugs, compounded preparations, devices, and retail products have different evidence, sourcing, storage, labeling, interaction, and recall questions. A dietary supplement is not FDA-approved to treat or prevent disease, and authorized health claims, structure/function claims, and disease claims have different regulatory limits.

Maintain a versioned product and claim file for products recommended or sold: identity and source, actual claim, intended audience, evidence and limitations, owner, date, and approval. California prohibits false, fraudulent, misleading, or deceptive professional advertising. A scientific claim needs reliable, peer-reviewed, published studies, and a superiority claim needs objective scientific substantiation. A physician may not describe a functional or integrative credential as "board certified" unless it meets the statutory conditions, including comparable prominence for the full board name. FTC guidance requires health claims to have adequate substantiation. A disclaimer does not make an unsupported claim safe.

For compounded drugs, identify the formulation, compounder, reason an FDA-approved alternative cannot meet the patient's medical need, patient-specific or office-use workflow, storage, lot and recall path, and patient reachability. Compounded drugs are not FDA-approved; "compounded" alone is neither a safety conclusion nor a coverage answer. A 503A pharmacy and a 503B outsourcing facility work under different federal pathways; do not treat either label as proof that a product is appropriate for this patient.

Coaching extends care only when the handoff is explicit

Use a title neither as a scope analysis nor as a substitute for clinical authority. Define what coaches and other staff collect or teach, what they document, what they cannot decide, the red flags that trigger escalation, the named clinical recipient, the response timeframe, and documented closure. Diagnosis, prescribing, treatment changes, test interpretation, and triage belong with the person authorized for that task under the applicable license and practice arrangement.

Keep one authoritative medical record. Reconcile tests, pharmacy questions, supplements, wearable data, consultant reports, missed follow-up, and handoff to primary or specialty care there.

For a California practice, a California-licensed physician must retain ultimate responsibility for and approval of clinical decisions, including appropriate tests, referrals, treatment options, medical-record control, clinical hiring and competency, and selection of medical equipment and supplies. A management company can provide administrative services but cannot arrange for, advertise, or provide medical services.

Let coverage verify the actual practice

Telehealth, mail, mobile care, and retail sales change the setting but do not remove clinical duties. California telehealth requires documented patient consent and does not change scope, standard-of-care, confidentiality, or record duties. When an online model prescribes, dispenses, or furnishes a dangerous drug, it also needs an appropriate prior examination and medical indication; the method of examination must meet the standard of care.

A periodic membership fee does not automatically make a practice a health care service plan. But a model that undertakes to arrange care, or to pay or reimburse for care, for subscribers or enrollees can meet California's statutory definition. Assess the actual membership promise, entity, and advertising before launch rather than relying on the label "direct pay."

Only after the care model is clear should the practice compare its actual entities, people, sites, tests, products, platform vendors, revenue flows, and after-hours work to the application, declarations, definitions, endorsements, exclusions, named insureds, and contracts. Use the broker's written response to identify the relevant issued terms; it does not amend them. The issued policy and endorsements control.

For claims-made coverage, preserve the date of each new test, product, clinician, site, or entity. The NAIC explains that claims-made coverage generally responds under the policy in force when the claim is reported, subject to its terms and any extended reporting period.

Before launch, ask: What clinical claim, product, data flow, and after-hours responsibility will exist on day one that was absent from the application? If the team cannot answer, the philosophy has outrun the clinical system.

An integrative label does not lower the standard of clinical thinking.